Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Syndrome”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Not applicableLooking for participantsNCT06455332
What this trial is testing

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University Hospital, Lille 200
Not applicableUnknownNCT02862301
What this trial is testing

Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome

Who this might be right for
Demyelinating Autoimmune Diseases, CNS
Centre Hospitalier Universitaire de Besancon 55
Large-scale testing (Phase 3)Study completedNCT02746744
What this trial is testing

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Anders Svenningsson 200
Not applicableStudy completedNCT03438357
What this trial is testing

Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Centre Hospitalier Universitaire de Nīmes 200
Not applicableEnded earlyNCT04599023
What this trial is testing

Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Insel Gruppe AG, University Hospital Bern 182
Testing effectiveness (Phase 2)Study completedNCT01450124
What this trial is testing

Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 29
Testing effectiveness (Phase 2)Looking for participantsNCT05418010
What this trial is testing

Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome of Demyelination
Queen Mary University of London 40
Not applicableActive Not RecruitingNCT05057676
What this trial is testing

Autoimmune Intervention Mastery Course Study

Who this might be right for
Multiple SclerosisClinically Isolated SyndromeFibromyalgia+2 more
Terry L. Wahls 400
Large-scale testing (Phase 3)Study completedNCT00666224
What this trial is testing

Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 481
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Not applicableUnknownNCT05277740
What this trial is testing

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

Who this might be right for
Clinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis
McGill University 120
Not applicableLooking for participantsNCT06280755
What this trial is testing

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
icometrix 7,000
Testing effectiveness (Phase 2)Ended earlyNCT00595920
What this trial is testing

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome
Opexa Therapeutics, Inc. 116
Post-approval studies (Phase 4)Study completedNCT04998851
What this trial is testing

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Hoffmann-La Roche 26
Large-scale testing (Phase 3)Study completedNCT00725985
What this trial is testing

Oral Cladribine in Early Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 617
Not applicableStudy completedNCT00704834
What this trial is testing

Gene Expression Profiles in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of California, Davis 46
Testing effectiveness (Phase 2)Ended earlyNCT01413243
What this trial is testing

Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Charite University, Berlin, Germany 50
Not applicableLooking for participantsNCT06541626
What this trial is testing

Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases

Who this might be right for
Multiple Sclerosis, MSNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 450
Post-approval studies (Phase 4)Active Not RecruitingNCT04466150
What this trial is testing

Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated Syndrome
University of California, San Francisco 30
Next Page